References
- Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013;122:1122–31
- Stamatopoulou A, Cowans NJ, Matwejew E, et al. Placental protein-13 and pregnancy-associated plasma protein-A as first trimester screening markers for hypertensive disorders and small for gestational age outcomes. Hypertens Pregnancy 2011;30:384–95
- Poon LC, Chelemen T, Granvillano O, et al. First-trimester maternal serum a disintegrin and metalloprotease 12 (ADAM12) and adverse pregnancy outcome. Obstet Gynecol 2008;112:1082–90
- Audibert F, Boucoiran I, An N, et al. Screening for preeclampsia using first—trimester serum markers and uterine artery Doppler in nulliparous women. Am J Obstet Gynecol 2010;203:383.e381–8
- Goetzinger KR, Singla A, Gerkowicz S, et al. Predicting the risk of pre-eclampsia between 11 and 13 weeks' gestation by combining maternal characteristics and serum analytes, PAPP-A and free beta-hCG. Prenat Diagn 2010;30:1138–42
- Odibo AO, Patel KR, Spitalnik A, et al. Placental pathology, first-trimester biomarkers and adverse pregnancy outcomes. J Perinatol 2014;34:186–91
- Poon LC, Akolekar R, Lachmann R, et al. Hypertensive disorders in pregnancy: screening by biophysical and biochemical markers at 11–13 weeks. Ultrasound Obstet Gynecol 2010;35:662–70
- Myatt L, Clifton RG, Roberts JM, et al. First–trimester prediction of preeclampsia in nulliparous women at low risk. Obstet Gynecol 2012;119:1234–42
- Bramham K, Briley AL, Seed P, et al. Adverse maternal and perinatal outcomes in women with previous preeclampsia: a prospective study. Am J Obstet Gynecol 2011;204:512.e1–9
- Myers JE, Kenny LC, McCowan LM, et al; SCOPE consortium. Angiogenic factors combined with clinical risk factors to predict preterm pre-eclampsia in nulliparous women: a predictive test accuracy study. BJOG 2013;120:1215–23
- Lyell DJ, Lambert-Messerlian GM, Giudice LC. Prenatal screening, epidemiology, diagnosis, and management of preeclampsia. Clin Lab Med 2003;23:413–42
- Barden AE, Beilin LJ, Ritchie J, et al. Is proteinuric pre-eclampsia a different disease in primigravida and multigravida? Clin Sci (London, England: 1979) 1999;97:475–83
- Poon LC, Nicolaides KH. First-trimester maternal factors and biomarker screening for preeclampsia. Prenat Diagn 2014;34:618–27
- Park FJ, Leung CH, Poon LC, et al. Clinical evaluation of a first trimester algorithm predicting the risk of hypertensive disease of pregnancy. Aust N Z J Obstet Gynaecol 2013;53:532–9
- Cuckle HS. Screening for pre-eclampsia – lessons from aneuploidy screening. Placenta 2011;32:S42–8
- Henderson JT, Whitlock EP, O'Connor E, et al. Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med 2014;160:695–703